These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 28222771)

  • 21. HSV-tk/GCV gene therapy mediated by EBV-LMP1 for EBV-associated cancer.
    Lifang Y; Min T; Midan A; Ya C
    J Exp Clin Cancer Res; 2008 Sep; 27(1):42. PubMed ID: 18811956
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of digoxin on cell cycle, apoptosis and NF-κB pathway in Burkitt's lymphoma cells and animal model.
    Wang T; Xu P; Wang F; Zhou D; Wang R; Meng L; Wang X; Zhou M; Chen B; Ouyang J
    Leuk Lymphoma; 2017 Jul; 58(7):1673-1685. PubMed ID: 28084852
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Latent membrane protein 1 of Epstein-Barr virus sensitizes cancer cells to cisplatin by enhancing NF-κB p50 homodimer formation and downregulating NAPA expression.
    Wu ZZ; Chow KP; Kuo TC; Chang YS; Chao CC
    Biochem Pharmacol; 2011 Dec; 82(12):1860-72. PubMed ID: 21945668
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Wogonin inhibits H2O2-induced angiogenesis via suppressing PI3K/Akt/NF-κB signaling pathway.
    Zhou M; Song X; Huang Y; Wei L; Li Z; You Q; Guo Q; Lu N
    Vascul Pharmacol; 2014 Mar; 60(3):110-9. PubMed ID: 24534483
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Triptolide inhibits proliferation of Epstein-Barr virus-positive B lymphocytes by down-regulating expression of a viral protein LMP1.
    Zhou H; Guo W; Long C; Wang H; Wang J; Sun X
    Biochem Biophys Res Commun; 2015 Jan; 456(3):815-20. PubMed ID: 25511707
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bortezomib induces apoptosis of Epstein-Barr virus (EBV)-transformed B cells and prolongs survival of mice inoculated with EBV-transformed B cells.
    Zou P; Kawada J; Pesnicak L; Cohen JI
    J Virol; 2007 Sep; 81(18):10029-36. PubMed ID: 17626072
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Wogonin suppresses inflammatory response and maintains intestinal barrier function via TLR4-MyD88-TAK1-mediated NF-κB pathway in vitro.
    Wang W; Xia T; Yu X
    Inflamm Res; 2015 Jun; 64(6):423-31. PubMed ID: 25917044
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The latent membrane protein 1 (LMP1) encoded by Epstein-Barr virus induces expression of the putative oncogene Bcl-3 through activation of the nuclear factor-kappaB.
    Nakamura H; Ishii C; Suehiro M; Iguchi A; Kuroda K; Shimizu K; Shimizu N; Imadome K; Yajima M; Fujiwara S
    Virus Res; 2008 Feb; 131(2):170-9. PubMed ID: 17963943
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Histone deacetylase inhibitor romidepsin induces efficient tumor cell lysis via selective down-regulation of LMP1 and c-myc expression in EBV-positive diffuse large B-cell lymphoma.
    Shin DY; Kim A; Kang HJ; Park S; Kim DW; Lee SS
    Cancer Lett; 2015 Aug; 364(2):89-97. PubMed ID: 25790907
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Icaritin induces lytic cytotoxicity in extranodal NK/T-cell lymphoma.
    Wu T; Wang S; Wu J; Lin Z; Sui X; Xu X; Shimizu N; Chen B; Wang X
    J Exp Clin Cancer Res; 2015 Feb; 34(1):17. PubMed ID: 25887673
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epstein-Barr virus encoded LMP1 downregulates TCL1 oncogene through miR-29b.
    Anastasiadou E; Boccellato F; Vincenti S; Rosato P; Bozzoni I; Frati L; Faggioni A; Presutti C; Trivedi P
    Oncogene; 2010 Mar; 29(9):1316-28. PubMed ID: 19966860
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epstein-Barr virus encoded latent membrane protein 1 induces TRAF1 expression to promote anti-apoptosis activity via NF-kappaB signaling pathway in nasopharyngeal carcinoma.
    Wang C; Ai M; Ren W; Xiao H; Li X; Tang F; Gu H; Yi W; Weng X; Deng X; Cao Y
    Chin Med J (Engl); 2003 Jul; 116(7):1022-8. PubMed ID: 12890376
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Induction of epidermal growth factor receptor expression by Epstein-Barr virus latent membrane protein 1 C-terminal-activating region 1 is mediated by NF-kappaB p50 homodimer/Bcl-3 complexes.
    Thornburg NJ; Raab-Traub N
    J Virol; 2007 Dec; 81(23):12954-61. PubMed ID: 17881446
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Resveratrol inhibits proliferation and survival of Epstein Barr virus-infected Burkitt's lymphoma cells depending on viral latency program.
    De Leo A; Arena G; Stecca C; Raciti M; Mattia E
    Mol Cancer Res; 2011 Oct; 9(10):1346-55. PubMed ID: 21856773
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epstein-Barr virus latent membrane protein-1 protects B-cell lymphoma from rituximab-induced apoptosis through miR-155-mediated Akt activation and up-regulation of Mcl-1.
    Kim JH; Kim WS; Park C
    Leuk Lymphoma; 2012 Aug; 53(8):1586-91. PubMed ID: 22268450
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regulation of the MIR155 host gene in physiological and pathological processes.
    Elton TS; Selemon H; Elton SM; Parinandi NL
    Gene; 2013 Dec; 532(1):1-12. PubMed ID: 23246696
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeted Therapy for EBV-Associated B-cell Neoplasms.
    Ganguly S; Kuravi S; Alleboina S; Mudduluru G; Jensen RA; McGuirk JP; Balusu R
    Mol Cancer Res; 2019 Apr; 17(4):839-844. PubMed ID: 30487243
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epstein-Barr virus and a cellular signaling pathway in lymphomas from immunosuppressed patients.
    Liebowitz D
    N Engl J Med; 1998 May; 338(20):1413-21. PubMed ID: 9580648
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The novel inhibitor BRM270 downregulates tumorigenesis by suppression of NF-κB signaling cascade in MDR-induced stem like cancer-initiating cells.
    Mongre RK; Sodhi SS; Ghosh M; Kim JH; Kim N; Park YH; Kim SJ; Heo YJ; Sharma N; Jeong DK
    Int J Oncol; 2015; 46(6):2573-85. PubMed ID: 25872586
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The copy number of Epstein-Barr virus latent genome correlates with the oncogenicity by the activation level of LMP1 and NF-κB.
    Zuo L; Yu H; Liu L; Tang Y; Wu H; Yang J; Zhu M; Du S; Zhao L; Cao L; Li G; Lu J
    Oncotarget; 2015 Dec; 6(38):41033-44. PubMed ID: 26517512
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.